CLASS II Device recall · Reported 19 May 2021 · FDA Enforcement Report

Revogene Sars-CoV recalled by Meridian Bioscience

Meridian Bioscience is recalling Revogene Sars-CoV-2, distributed nationwide in the US. The recall was initiated on 8 Apr 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lot numbers
Quantity recalled376 kits of the Revogene SARS-CoV-2 assay

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1540-2021
FDA event ID
87556
Recalling firm
Meridian Bioscience, Cincinnati, OH
Classification
Class II
Status
Terminated
Recall initiated
8 Apr 2021
FDA classified
7 May 2021
Reported
19 May 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

8 Apr 2021Recall initiated by company
7 May 2021Classified by FDA+29 days
19 May 2021Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Emergency Use Application (EUA) application withdrawn as false negative results reported

Product as listed by the FDA

Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene¿ instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal swab (NPS) specimens from individuals suspected of COVID-19

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Emergency Use Application (EUA) application withdrawn as false negative results reported

Which lots are affected?

All lot numbers

Where was it sold?

Nationwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 87556
ReportedClassRecallCompanyReasonWhere
CLASS IIRevogene RNA recalled by Meridian BioscienceMeridian BiosciencePotency & AssayNationwide

More recalls from Meridian Bioscience

All 15

Other Test Kits & Diagnostics recalls

All 2,663